DeepSeq.AI

We are excited to announce that DeepSeq has been awarded a DARPA contract under its Biological Technologies Office (BTO) AI BTO Pitch Day initiative, one of a few awardees chosen from about 500 applicants! DeepSeq is one of just 16 DARPA AI BTO Pitch Day awardees in our area of Biomanufacturing/Synthetic Biology, and we understand the only awardee in our area with the scope of advancing a generalized AI/assay-based protein drug discovery platform to help tackle future pandemic threats, aligning with DARPA AI BTO's mission to drive transformative science. We are truly grateful for DARPA's trust in our vision, and look forward to working together to help shape a more resilient future for global human health. https://lnkd.in/g3rNF83x #DeepSeqAI #AIBTO #Innovation #GlobalHealth #AIDrugDiscovery

I'm pleased to share a very nice article in the Times Union today about our collaboration with DeepSeq.AI funded by the National Science Foundation (NSF) advancing antibody biomanufacturing by using AI to identify sequences that are easily expressed. Check out the pictures of some of my team Paria Baninoe and Setare Adibzadeh. Setare is the postdoctoral fellow doing the hands-on experiments. https://lnkd.in/eB26cxBA

We're excited to share a major milestone: DeepSeq.AI has partnered with Gilead to harness our Generative AI-powered platform for the next frontier of biologics design and screening! This collaboration combines DeepSeq's explainable AI and wet lab expertise to accelerate the discovery of high-quality biologics, pushing the boundaries of multifunctional optimization at scale. Together, we aim to advance protein design, delivering innovative treatments that truly make a difference for patients. We're honored to work with Gilead's outstanding team as we embark on this journey to revolutionize biologics design. https://lnkd.in/ghiJpzYR #Gilead #DeepSeqAI #AIDrugDiscovery #GenerativeAI #ExplainableAI #SyntheticBiology #ProteinEngineering

We are thrilled to announce that DeepSeq.AI has won the 2024 Golden Ticket Competition, sponsored by Ono Pharmaceutical and MBC BioLabs. This prestigious award grants us one year of complimentary lab space at MBC BioLabs in San Francisco, renowned for its cutting-edge facilities and vibrant biotech community that has launched industry-leading companies. Being recognized for our work in building an end-to-end platform that leverages the full potential of AI and synthetic biology is an incredible honor. The Golden Ticket will propel our mission of revolutionizing protein drug discovery through our scalable data generation platform and explainable AI approach. A big thank you to #ONO and #MBCBioLabs for their support and belief in our vision. We’re excited to accelerate our research and to be part of this incredible community! To read full article: https://lnkd.in/gYY4cpMu #AI #ExplainableAI #DeepSeqAI #ProteinEngineering #Biotech #SyntheticBiology

We're thrilled to announce that DeepSeq.AI has been awarded?the NSF?SBIR Phase I grant! This prestigious grant highlights the groundbreaking potential of our AI platform, which revolutionizes protein drug discovery by optimizing multiple drug properties through explainable AI and our unique wet-lab screening. With this support, we'll expand our proprietary datasets and enhance our platform's ability to explore a broader protein functional space, driving significant advancements in AI-driven drug discovery. This achievement underscores our commitment to advancing the efficiency and effectiveness of large-molecule drug discovery.?https://lnkd.in/g9QPtf5u